Skip to main content
Signal8
Kolean Chad J profile photo

Chad J. Kolean

CIK: 0001616753

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Cellectar Biosciences, Inc. logo
CLRB

Cellectar Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Cellectar Biosciences, Inc. logo
    CLRB

    Cellectar Biosciences, Inc.

    Jul 7, 2026
    Award(A)

    Stock option (right to buy)

    Direct
    92K shares-
  • Cellectar Biosciences, Inc. logo
    CLRB

    Cellectar Biosciences, Inc.

    Jul 2, 2025
    Purchase(P)
    Direct
    5K shares at avg. $4.99$25K
  • Cellectar Biosciences, Inc. logo
    CLRB

    Cellectar Biosciences, Inc.

    Feb 14, 2025
    Award(A)

    Stock option (right to buy)

    Direct
    290K shares-

1-3 of 3

About Kolean Chad J

Kolean Chad J (SEC CIK 0001616753) files insider reports with the SEC as CFO of Cellectar Biosciences, Inc. (CLRB).

Signal8 holds 3 ownership filings by Kolean Chad J, all Form 4s, filed between Feb 18, 2025 and Jul 8, 2026. Those filings report 3 transactions, from Feb 14, 2025 to Jul 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kolean Chad J's filings is in FLORHAM PARK, NJ.

Recent filings by Kolean Chad J

  • Jul 7, 2026: Grant or award of CLRB derivative securities (Form 4, code A).
  • Jul 2, 2025: Open-market purchase of CLRB shares (Form 4, code P).
  • Feb 14, 2025: Grant or award of CLRB derivative securities (Form 4, code A).

Other insiders filing for Cellectar Biosciences, Inc. (CLRB)

How to read Form 4 transaction codes